Acquired RAS or EGFR mutations and duration of response to EGFR blockade in colorectal cancer

B.O. Van Emburgh, S. Arena, G. Siravegna, L. Lazzari, G. Crisafulli, G. Corti, B. Mussolin, F. Baldi, M. Buscarino, A. Bartolini, Emanuele Valtorta, Maria J. Vidal, Beatriz Bellosillo, G. Germano, F. Pietrantonio, Agostino Ponzetti, J. Albanell, S. Siena, A. Sartore-Bianchi, F. Di NicolantonioClara Montagut, A. Bardelli

Research output: Contribution to journalArticle

Cite this

Van Emburgh, B. O., Arena, S., Siravegna, G., Lazzari, L., Crisafulli, G., Corti, G., Mussolin, B., Baldi, F., Buscarino, M., Bartolini, A., Valtorta, E., Vidal, M. J., Bellosillo, B., Germano, G., Pietrantonio, F., Ponzetti, A., Albanell, J., Siena, S., Sartore-Bianchi, A., ... Bardelli, A. (2016). Acquired RAS or EGFR mutations and duration of response to EGFR blockade in colorectal cancer. Nature Communications, 7. https://doi.org/10.1038/ncomms13665